North Run Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,070,000
| Closed | -$38.8M | – | 20 |
|
|
2016
Q4 | $38.8M | Buy |
1,070,000
+255,000
| +31% | +$9.24M | 11.85% | 3 |
|
|
2016
Q3 | $37.5M | Sell |
815,000
-40,000
| -5% | -$1.84M | 5.89% | 7 |
|
|
2016
Q2 | $42.9M | Sell |
855,000
-15,000
| -2% | -$753K | 7.08% | 2 |
|
|
2016
Q1 | $46.6M | Buy |
870,000
+45,000
| +5% | +$2.41M | 6.38% | 5 |
|
|
2015
Q4 | $54.2M | Sell |
825,000
-200,000
| -20% | -$13.1M | 6.39% | 5 |
|
|
2015
Q3 | $57.9M | Buy |
1,025,000
+125,000
| +14% | +$7.06M | 5.68% | 5 |
|
|
2015
Q2 | $53.2M | Buy |
900,000
+150,000
| +20% | +$8.87M | 5.22% | 6 |
|
|
2015
Q1 | $46.7M | Hold |
750,000
| – | – | 5.11% | 10 |
|
|
2014
Q4 | $43.1M | Hold |
750,000
| – | – | 3.84% | 13 |
|
|
2014
Q3 | $40.3M | Sell |
750,000
-110,000
| -13% | -$5.91M | 3.65% | 13 |
|
|
2014
Q2 | $45.1M | Sell |
860,000
-315,000
| -27% | -$16.5M | 4.38% | 13 |
|
|
2014
Q1 | $62.1M | Sell |
1,175,000
-1,175,000
| -50% | -$62.1M | 6.31% | 2 |
|
|
2013
Q4 | $94.2M | Buy |
+2,350,000
| New | +$94.2M | 11.93% | 1 |
|